Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
about
Emerging drugs for Duchenne muscular dystrophyComparison of Experimental Protocols of Physical Exercise for mdx Mice and Duchenne Muscular Dystrophy Patients.Roles of nonmyogenic mesenchymal progenitors in pathogenesis and regeneration of skeletal muscle.Identification and characterization of PDGFRα+ mesenchymal progenitors in human skeletal muscle.Targeting fibrosis in Duchenne muscular dystrophy.Tissue-resident mesenchymal stem/progenitor cells in skeletal muscle: collaborators or saboteurs?Drug Discovery of Therapies for Duchenne Muscular Dystrophy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophyUnderstanding the process of fibrosis in Duchenne muscular dystrophy.Aberrant repair and fibrosis development in skeletal muscle.Inhibition of the angiotensin-converting enzyme decreases skeletal muscle fibrosis in dystrophic mice by a diminution in the expression and activity of connective tissue growth factor (CTGF/CCN-2).Effect of imatinib on airway smooth muscle thickening in a murine model of chronic asthma.
P2860
Q36363716-EBA05B98-5C0D-462F-886B-EA2391E74ADEQ37589749-27F7A649-9E64-4ACB-AF88-4B7F40870349Q37598995-13169A1A-62E1-42E8-B7CF-F3DF1ABD2C8AQ37726150-80BC0E68-DCB2-4A4B-9F1C-BFFCB8FFE11EQ37770947-08E293E0-BCDC-4244-869A-D268C48C63BCQ38114163-16347FA3-1CE9-4F96-8642-63B4AE4A732BQ38480698-7408273A-1347-433C-A689-487D78CADA43Q39410461-0479EE95-CB34-441B-AEF7-D267C589B9D8Q39699112-BA3832B7-1A49-4281-A465-F3C91EA049ECQ41822988-CE25C801-6B6C-4309-944D-A68A0B5F0AF5Q50994524-5AD8623B-8E6C-4A73-AF97-5312183F2283Q53439673-AD466BE0-88C9-4EDE-9AF6-335AAC547EDB
P2860
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@en
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@nl
type
label
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@en
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@nl
prefLabel
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@en
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@nl
P2093
P1476
Imatinib mesylate ameliorates the dystrophic phenotype in exercised mdx mice.
@en
P2093
Auro Nomizo
Daniel Giuliano Cerri
Daniela Dover de Araujo
Fabíola Attié de Castro
Gislane L V Oliveira
João Carlos da Silva Bizario
Juliana Caldas Ribeiro
Lilian Cataldi Rodrigues
Maria Cristina Ramos Costa
Paula Sakemi Fukuhara
P304
P356
10.1016/J.JNEUROIM.2009.05.006
P577
2009-06-09T00:00:00Z